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The Roles of Fas/APO-1 (CD95) and TNF
in Antigen-Induced Programmed Cell Death
in T Cell Receptor Transgenic Mice
Huey-Kang Sytwu,* Roland S. Liblau,*‡ of thymus-derived, T cell receptor (TCR)a/b1, CD31,
CD42, CD82 double-negative (DN) T cells (reviewed byand Hugh O. McDevitt*†
Cohen and Eisenberg, 1991). It has recently been dem-*Departments of Microbiology and Immunology
onstrated that the lpr mouse has a genetic defect in Fas†Department of Medicine
and the gld mouse in the complementary Fas ligandStanford University School of Medicine
(FasL) (Itoh et al., 1991; Suda et al., 1993; Takahashi etStanford, California 94305
al., 1994). Furthermore, the interaction between Fas and
its specific monoclonal antibody (anti-Fas antibody) or
FasL induces T cell apoptosis (Yonehara et al., 1989;Summary
Trauth et al., 1989). Based on these findings, it has been
postulated that these unusual DN T cells fail to undergoThe possible involvement of Fas/APO-1 (CD95) and
Fas-mediated apoptosis, accumulate in peripheralTNF in antigen-specific AICD of thymocytes and ma-
lymphoid organs, and cause progressive lymphadenop-ture T cells has been investigated. Antigenic stimula-
athy. However, it is still unclear whether Fas-mediatedtion in vivo of influenza hemagglutinin (HA)-specific
apoptosis occurs in the thymus or the periphery, or both.TCRtg mice was used to demonstrate that the kinetics
Fas is expressed in activated mature T cells in theof thymocyte and peripheral CD41 T cell deletion are
periphery (Drappa et al., 1993). Prolonged activation ofsimilar in mice with normal (1/1) or defective Fas (lpr/
mature T cells renders the cells more susceptible to thelpr) background, indicating that a Fas-independent
cytolytic activity of anti-Fas antibody (Owen-Schaub etpathway(s) is responsible for the deletion of activated
al., 1992; Klas et al., 1993). Recent studies on mature TT cells. TCRtg–1/1 orTCRtg–lpr/lpr mice injected with
cells from lpr and gld mice indicated that these T cellsmurine TNF-blocking MAb (TN3) showed rapid apop-
were resistant to anti-CD3-stimulated suicide (Russelltosis of thymocytes after HA stimulation, indicating
et al., 1993; Russell and Wang, 1993) and were defectivethat death signaling through Fas and TNF receptors
in the deletion of the Vb81 T cell subset following in vivois not essential for HA-induced thymocyte deletion.
administration of superantigen (Staphylococcal entero-CD41 peripheral T cells in TCRtg–lpr/lpr mice did not
toxin B, SEB) (Scott et al., 1993). Further in vitro studiesundergo apoptosis following injection with HA and
of Fas-mediated T cell apoptosis in an autocrine mannerTN3, indicating that TNF-mediated apoptosis is in-
have provided a mechanism for suppression of the im-volved in the deletion of mature T cells after antigenic
mune response and for peripheral tolerance by T cellstimulation. However, apoptosis still occurred in
deletion (Dhein et al., 1995; Brunner et al., 1995; Ju etTCRtg–1/1 mice injected with TN3, indicating that
al., 1995).
both Fas- and TNF-mediated cell death can contribute
These results suggest a role for Fas in the induction
to the deletion of activated peripheral T cells.
of peripheral deletion of activated T cells undergoing
excessive clonal expansion after antigen or superanti-
Introduction gen stimulation. In accordance with this model, activa-
tion of mature T cells induces the expression of FasL
Lymphocyte development is regulated not only by prolif- (Suda et al., 1993). It has also been hypothesized that
eration and differentiation but also by cell death (Kappler activated T cells expressing bothFas and FasL are killed
et al., 1987; Smith et al., 1989; Shi et al., 1991; reviewed by themselves or by interacting with each other (re-
by Ellis et al., 1991; Raff, 1992). Cell death, most of which viewed by Crispe, 1994). Such a mechanism may oper-
proceeds via apoptosis (programmed cell death),occurs ate not only to delete autoreactive T cells but also to
duringdevelopment or tissue turnover (reviewed by Wyl- remove activated T cells specific for foreign antigens
lie et al., 1980; Walker et al., 1988). However, the molecu- after they have done their job. This model is supported
lar mechanisms of cell death in mammals are still poorly by the in vivo finding that Fas is involved in peripheral
understood, despite their importance during develop- T cell deletion afterhigh dose antigen stimulation (Singer
ment. Fas/APO-1(CD95), a member of the tumor necro- and Abbas, 1994). However, detailed information about
sis factor (TNF)/nerve growth factor (NGF) receptor fam- the role of Fas in the control of T cell responses, e.g.,
ily appears to play an important role in programmed activation of T cells, induction of anergy, and kinetics
cell death during T cell development (Itoh et al., 1991; of T cell deletion, still remains to be elucidated. Further-
Watanabe-Fukunaga et al., 1992a, 1992b; Tartaglia et more, antigen-stimulated T cell responses and the sub-
al., 1993). sequent fate of these activated T cells could vary in
The biological function and the physiological role of different TCRtg models due to differences in TCR affin-
Fas-mediated apoptosis in T cell development remain ity, TCR transgene expression, usage of TCR Va and Vb
unclear. Mice homozygous for lpr (l) lymphoproliferation repertoires, or major histocompatibility complex (MHC)
or gld (l) generalized lymphoproliferative disease spon- restriction. Therefore, we introduced the mutant Fas
taneously develop lymphadenopathy characterized by gene (lpr/lpr) into another TCRtg mouse line (HNT–
the progressive accumulation of an unusual population TCRtg), in which the kinetics of high dose antigen-
induced T cell hyporesponsiveness and apoptosis have
been well characterized (Liblau et al., 1996).‡Current address: Cellular Immunology Laboratory and INSERM
U134, Hoˆpital Pitie-Salpetriere, Paris 75013, France. More than 99% of TCRhi thymocytes and peripheral
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T cells in HNT–TCRtg mice express the Vb8.3 transgene of ETn (Figure 1A). Failure to synthesize a DNA fragment
from primers 1 and 2 in the presence of ETn leaves only(Scott et al., 1994). High dose (750 mg) intravenous injec-
tion of antigen (hemagglutinin [HA] 126–138) caused the amplified 254 bp product from primers 1 and 3 in
lpr/lpr mice on either the MRL or B6 background. In therapid antigen-specific thymocyte apoptosis and initial
activation of peripheral T cells followed by programmed absence of ETn, the only product from primers 1 and 2
in wild-type mice is 327 bp. Both products are detectedcell death and anergy of the surviving T cells. By the
in situ terminal deoxynucleotidyl transferase-mediated in heterozygotes (Figure 1B).
To confirm further the lack of Fas expression indUTP-biotin nick end labeling (TUNEL) assay, the deple-
tion of thymocytes and peripheral CD41 T cells was TCRtg–lpr/lpr mice, thymocytes from TCRtg mice with
different Fas genotypes were prepared and stainedshown to be mediated by apoptosis (Liblau et al., 1996).
By introducing the lpr/lpr gene into this TCRtg line, we with phycoerythrin-conjugated hamster anti-mouse Fas
(Jo2). T cells from lpr/lpr mice had no detectable surfacewere able to evaluate the role of Fas in thymic negative
selection and in peripheral elimination of activated T expression of Fas, compared with T cells from Fas 1/1
or 1/lpr mice (Figure 1C). The results also indicated thatlymphocytes. Our results demonstrate the existence of
a Fas-independent death pathway responsible for the 1/1 and 1/lpr T cells expressed similar levels
of Fas.deletion of activated thymic or peripheral T cells in
TCRtg–lpr/lpr mice. TNF, another apoptosis-associated
molecule that shares amino acid homology with FasL,
Phenotype of TCRtg–lpr/lpr Mice and Theirhas recently been shown to induce apoptosis of acti-
T Cell Responses to In Vitrovated lymphocytes from lpr/lpr mice in vitro (Zheng et
and In Vivo HA Stimulational., 1995). Therefore, we investigated the possible effect
To evaluate the possible disturbance of T cell develop-of TNF on antigen-induced T cell apoptosis and hypore-
ment caused by introducing the lpr mutation from thesponsiveness by injection of anti-TNF monoclonal anti-
MRL or B6 background into HNT–TCRtg mice, thymus,body (MAb) (TN3) in either wild-type or mutant Fas
spleen, and lymph nodes from TCRtg-1/1, TCRtg–1/TCRtg mice. In summary, our results indicate that both
lpr, and TCRtg–lpr/lpr mice (6–8 weeks of age) wereFas- and TNF-mediated apoptosis contribute to the
prepared, stained, and analyzed by flow cytometry anddeath of peripheral T cells after antigenic stimulation,
the total T cell number and the distribution of each com-but are not essential for thymic negative selection.
partment were compared in these mice. Although the
transgenic TCR in the HNT mouse is restricted by I-Ad,
this mouse does not show skewing towards the CD4Results
single-positive (SP) population in the thymus, spleen, or
lymph nodes (Scott et al., 1994). This is unlike most, butGeneration of TCRtg Mice with the
lpr/lpr Mutation not all (Kirberg et al., 1994), other class II MHC-restricted
TCRtg mice. TCRtg–lpr/lpr mice had similar T cell num-To knockout functionally the Fas gene in HNT–TCRtg
mice, mice transgenic for an I-Ad-restricted HA-specific bers and the same distribution of each subpopulation
in the thymus, spleen, and lymph nodes as shown inTCR were bred to MRL–lpr/lpr and C57BL/6–lpr/lpr
mice. F1 progeny with the TCR transgene were inter- TCRtg–1/1 or TCRtg–1/lpr mice (Figures 2A and 2B),
indicating that the lpr mutation did not disturb T cellcrossed with TCR transgene negative mice. Subsequent
generations were screened for the expression of the development in HNT–TCRtg mice. The expresion levels
of the TCR Vb8.3 transgene, CD3, and CD4 in TCRtg–lpr/TCR transgene and I-Ad by flow cytometry of peripheral
blood cells using MAbs against Vb8 (F23.1) and I-Ad lpr mice were the same as those in TCRtg–1/1 or
TCRtg–1/lpr mice (data not shown).(AMS-32.1), respectively. Homozygosity for the lpr/lpr
mutation was determined by polymerase chain reaction To evaluate whether TCRtg–lpr/lpr mice develop lu-
pus-like autoimmune disease, we determined the anti-(PCR) analysis of tail DNA. Based on the genomic struc-
ture and DNA sequence of the Fas gene in lpr mice DNA antibody level and rheumatoid factor (RF) in both
TCRtg–lpr/lpr and nontransgenic lpr/lpr littermates. The(Adachi et al., 1993), three specific PCR primers were
designed to discriminate between the 1/1, 1/lpr, or results in Figure 2C indicate that neither TCRtg–lpr/lpr
nor nontransgenic lpr/lpr littermates showed abnormallpr/lpr Fas genotypes. Primer 1 (sense) and primer 2
(antisense) are located outside the early transposable anti-DNA antibody or RF at age 6 weeks. However, since
the development of lymphadenopathy and lupus-likeelement (ETn, a 5.7 kb insert in the second intron of the
Fas gene). Primer 3 (antisense) is in the 59 LTR region disease in lpr mice is highly age-related, we also
(Figure 1 legend continued)
(B) Determination of lpr mutation by PCR. The PCR products amplified from tail DNA by a combination of three primers were analyzed on a
1.5% agarose gel and visualized by ethidium bromide fluorescence. Product(s) from either an MRL–lpr/lpr (lane 2) or B6–lpr/lpr (lane 3) mouse
was 254 bp, from HNT–TCRtg mouse with the wild-type Fas gene (lane 4) was 327 bp, and from F1 (MRL–lpr/lpr 3 HNT–TCRtg) (lane 5) were
both 254 and 327 bp.
(C) Histograms of Fas expression on thymocytes from mice with different Fas genotypes. The X axis indicates phycoerythrin fluorescence
(Fas) and the Y axis indicates relative cell number. The left panel indicates that cells were not stained and the right three panels indicate that
cells were stained with phycoerythrin-conjugated hamster anti-Fas (Jo2) antibody. These mice are F2 progeny from an (MRL–lpr/lpr 3
HNT–TCRtg) F1 intercross. Similar results were obtained in four other experiments.
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Figure 1. Generation and Determination of lpr/lpr Mutation in HNT–TCRtg Mice
(A) Genomic structure of Fas gene in lpr mice and primer sequences for PCR analysis. Three specific PCRprimers were designed to discriminate
the 1/1, 1/lpr, or lpr/lpr Fas genotypes. Primer 1 (sense) and primer 2 (antisense) are located outside the early transposable element. Primer
3 (antisense) is in the 59 LTR region of ETn.
(Figure 1 legend continued on previous page)
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Figure 2. Phenotype of TCRtg–lpr/lpr Mice and Their T Cell Responses to In Vitro and In Vivo HA Stimulation
(A) Comparison of thymocyte number in each compartment from TCRtg mice with different Fas genotypes. Thymus cells from TCRtg–1/1,
TCRtg–1/lpr, and TCRtg–lpr/lpr mice (6–8 weeks of age) were prepared and the number of total viable cells was determined in a hemocytometer
by trypan blue exclusion. Cells were stained with MAbs specific for CD4 and CD8. The number of each subpopulation was determined based
on the total cell number and the percentage of each subpopulation from the contour plot data of flow cytometry (Flasher). Values represent
mean 6 SEM for 6–9 mice. These mice are F2 progeny from an (MRL–lpr/lpr 3 HNT–TCRtg) F1 intercross.
(B) Comparison of splenocyte number in each compartment from TCRtg mice with different Fas genotypes. Splenocytes were prepared and
the number of each subpopulation was determined as in the procedures described in (A).
(C) Determination of anti-DNA (IgG2a) and RF (IgG2a) levels in TCRtg–lpr/lpr mice, nontransgenic lpr/lpr littermates, and MRL–lpr/lpr mice at
different ages. Results of anti-DNA antibody and RF are listed separately and are expressed as OD at 405 nm. Values represent mean 6 SEM
for three mice. TCRtg–lpr/lpr and nontransgenic lpr/lpr mice are F2 progeny from an (MRL–lpr/lpr 3 HNT–TCRtg) F1 intercross.
(D) Proliferative responses of splenic T cells to HA peptide in vitro. Spleen cells (8 3 105) from TCRtg–1/1, TCRtg–1/lpr, and TCRtg–lpr/lpr
mice were stimulated in vitro with a range of concentrations of HA 126–138 (1:5 serial dilutions from 10–0.0032 mg/ml). The proliferative
responses were measured by [3H]thymidine incorporation. Values represent mean 6 SEM for 4–6 mice.
(E) CD41 T cell counts and the percentage of viable cells at different time points during the in vitro HA stimulation. Spleen cells (8 3 105) from
TCRtg–1/1 and TCRtg–lpr/lpr mice were cultured with HA peptide at a concentration of 2 mg/ml. Cultured cells were counted, and stained
with fluorescein-conjugated anti-CD4 and propidium iodide at different timepoints. The absolute number of CD41 T cells and the percentage
of viable cells were determined by flow cytometry as described in Experimental Procedures. Values represent mean 6 SEM for three mice.
(F) CD69 expression from mice with different Fas genotypes injected 1 day earlier with 750 mg HA. Histograms represent data obtained after
gating for CD41 splenic T cells. The X axis indicates Texas red fluorescence (CD69) and the Y axis indicates relative cell number. The left
panel indicates cells from noninjected mice and the right two panels indicate cells from HA-injected mice. Similar results were obtained in
six other experiments.
(Figure 2 continued on next page)
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checked both TCRtg–lpr/lpr and nontransgenic lpr/lpr background (B10.D2 mixed with MRL or C57BL/6) in
these mice.mice at different ages (16 and 24 weeks old). The results
show that nontransgenic lpr/lpr mice developed severe The functional responses to in vitro and in vivo HA
stimulation in TCRtg–lpr/lpr mice were also examined.lymphadenopathy, but neither 16- nor 24-week-old
TCRtg–lpr/lpr mice accumulated abnormal CD42CD82 When cultured with a range of concentrations of HA in
vitro, the splenocytes prepared from TCRtg–lpr/lpr miceB2201 T cells in peripheral lymphoid organs, indicating
that the transgenic TCR can prevent lymphadenopathy proliferated in a similar dose-dependent manner as
those fromTCRtg–1/1 or TCRtg–1/lpr mice (Figure 2D).in lpr/lpr mice (data not shown). Both TCRtg and non-
transgenic lpr/lpr mice at the age of 16 or 24 weeks This result suggested that the lpr mutation does not
affect the T cell proliferative response to antigenstimula-showed abnormal anti-DNA antibody and RF levels (Fig-
ure 2C). However, the titers are less in TCRtg–lpr/lpr tion in vitro. However, the assays of [3H]thymidine incor-
poration could reflect a balance of proliferating as wellmice or nontransgenic littermates than in age-matched
MRL–lpr/lpr mice. The lack of lymphadenopathy in as dying T cells in response to TCR stimulation. To rule
out the possibility that the similar [3H]thymidine incorpo-TCRtg–lpr/lpr mice hasalso beenreported in some other
TCRtg systems, e.g., an MHC class I–restricted TCRtg ration of wild-type and lpr T cells, stimulated by peptide
in vitro, is caused by lpr T cells that proliferate poorly(Mountz et al., 1994) and a class II–restricted TCRtg
(Singerand Abbas, 1994). The development of lupus-like as well as undergo less apoptosis, the absolute number
of CD41 T cells during a 3 day experiment, as well asdisease (elevation of autoantibody and immunoglobulin
levels) seems independent of the TCRtg or of lymphade- the percentage of viable cells, has been determined.
The results in Figure 2E demonstrated that both wild-nopathy. The decreased anti-DNA antibody and RF lev-
els in TCRtg and nontransgenic lpr/lpr mice versus type and lpr T cells cultured with HA peptide showed
similar CD41 T cell numbers and similar percentages ofMRL–lpr/lpr mice could be due to the mixed genetic
Immunity
22
viable cells at different timepoints, indicating that both this possibility, CD41 T cell counts and viable cell recov-
ery were quantitated before and after the in vitro restimu-wild-type and lpr CD41 T cells underwent similar re-
sponses to in vitro HA stimulation. lation. The data in Figure 4B indicate that the number
of viable CD41 T cells from both 1/1 and lpr/lpr miceTCRtg–lpr/lpr mice expressed the T cell activation
markers CD69 (Figure 2F), CD44 (Pgp-1), and CD25 (IL- injected with peptide did not decrease during the 3 day
restimulation, and the number of dead cells did not sig-2R) (data not shown) at the same levels as those in
TCRtg–1/1 or TCRtg–1/lpr mice 1 day after injection nificantly increase. Taken together, these results sug-
gest that the reduction of T cell responses to HA in vitrowith HA (750 mg), suggesting that the lpr mutation did
not prevent in vivo HA-specific T cell activation. is not caused by the potential apoptosis of those T cells
restimulated with HA, and the defective Fas gene does
not affect the induction of T cell hyporesponsiveness.
HA-Induced Thymic and Peripheral T Cell Deletion Responses to HA peptide in vitro were strongly en-
in TCRtg–1/1 and TCRtg–lpr/lpr Mice hanced by addition of exogenous interleukin-2 (IL-2)
Since T cell development, maturation, and in vitro and to cultures from mice 1 day after the peptide injection
in vivo HA-specific T cell responses are similar in both (Figure 4C), suggesting that anergy of T cells was the
TCRtg–1/1 (or TCRtg–1/lpr) and TCRtg–lpr/lpr mice, major cause of the state of hyporesponsiveness. This
we next studied the effect of mutant Fas gene in thymic conclusion is also supported by the calcium flux experi-
negative selection and peripheral elimination of acti- ments: CD41 T cells from TCRtg–1/1 and TCRtg–lpr/
vated T cells. TCRtg–1/1 (or TCRtg–1/lpr) or TCRtg– lpr mice that were injected 24 hr earlier with peptide
lpr/lpr mice were injected intravenously with 750 mg responded poorly to HA ex vivo (data not shown).
HA 126–138 or a control peptide OVA 323–339, and
sacrificed on days 1, 3, 5, and 7 after injection. Thymi,
Effect of TNF on HA-Induced Thymic andspleens, and lymph nodes were prepared and stained
Peripheral T Cell Deletion in TCRtg–1/1with MAbs specific for Vb8, CD4, CD8, CD3, CD25,
and TCRtg–lpr/lpr MiceCD44, CD69, and Fas. After administration of high dose
The results described above show that the mutant Fasaqueous HA peptide, a massive depletion of thymocytes
gene does not prevent the induction of thymocyte andwas rapidly induced on day 1 in both TCRtg–1/1 (or
CD41 T cell apoptosis, and suggest that another Fas-TCRtg–1/lpr) and TCRtg–lpr/lpr mice. The deletion be-
independent pathway(s) is responsible for the deletioncame most obvious on day 3 (Figure 3A). The deletion
of activated T cells. To evaluate this possibility further,kinetics of double-positive (DP) (Figure 3B) or CD4 SP
the effect of TNF on the induction of thymocyte andthymocytes (Fig 3C) was the same in both lines. These
peripheral T cell apoptosis was examined by analyzingresults demonstrated that the lpr mutation does not
the T cell deletion kinetics of TCRtg–1/1 or TCRtg–lpr/affect thymocyte deletion after high dose antigen stimu-
lpr mice injected with HA peptide and a TNF-blockinglation.
MAb, TN3. As shown inFigure 5A, the numbers of thymo-Interestingly, both 1/1 and lpr/lpr mice showed simi-
cytes in wild-type and lpr/lpr TCRtg mice injected withlar deletion of peripheral T cells in spleenor lymph nodes
TN3 MAb alone were similar to those of mice withouton days 3, 5, and 7 following the transient activation
any treatment, indicating that the TN3 treatment was(expansion) phase seen on day 1 (Figure 3D). This initial
not toxic. Injection of TN3 MAb and HA peptide into Fasincrease and the following decrease of total splenocytes
1/1 and lpr/lpr TCRtg mice induced dramatic depletionwas predominantly due to the initial expansion of CD4
of thymocytes, although the kinetics were slightly slowerSP T cells followed by the deletion of these cells (Figure
in the lpr/lpr background (Figure 5B). These results3E). The number of CD8 SP T cells did not change during
showed that neither the Fas nor the TNF pathway isthe 7 day period (Figure 3F). The thymic and peripheral
essential for antigen-induced thymocyte deletion.deletion of T cells through apoptosis was documented
Interestingly, peripheral CD41 T cells from lpr/lpr miceby the TUNEL reaction assay (data not shown). These
injected with TN3 MAb showed a striking resistance toresults indicate that the defective Fas gene does not
HA-induced T cell deletion, indicating that neutralizationprevent antigen-specific activation-induced cell death
of TNF blocks activation-induced apoptosis in lpr/lpr(AICD) of mature T cells in TCRtg–lpr/lpr mice. This con-
mice (Figure 5C). In contrast, peripheral T cells fromclusion conflicts with the results of Singer and Abbas
wild-type Fas mice injected with TN3 MAb still under-(1994).
went significant T cell deletion after HA injection, with
similar kinetics as that from mice injected with HA pep-
tide alone. Treatment with the immunoglobulin isotype-HA-Induced Peripheral T Cell Hyporesponsiveness
in TCRtg–1/1 and TCRtg–lpr/lpr Mice matched control MAb L2 did not affect T cell deletion
in lpr/lpr mice, indicating that the blocking effect of TN3The proliferative response to HA of T cells from
TCRtg–1/1 or TCRtg–lpr/lpr mice injected with HA was MAb on peripheral CD41 T cell apoptosis is TNF specific
(Figure 5D).analyzed. Tcell responses to HA in vitro showed a similar
reduction in 1/1 and lpr/lpr mice 1 day after peptide In vitro T cell proliferative responses to HA in TCRtg–
lpr/lpr mice injected with TN3 and HA were also signifi-injection (Figure 4A). One possibility we should consider
is that the decrease of T cell responses to HA in vitro cantly decreased (Figure 5E). This result indicates that
even though these T cells were resistant to AICD, theyis due to those T cells that were highly activated and
cycling in vivo, and thus were more susceptible to un- were still susceptible to peptide-induced anergy.
The in situ terminal deoxynucleotidyl transferase (TdT)dergo apoptosis when rechallenged in vitro. To rule out
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Figure 3. HA-Induced Thymic and Peripheral T Cell Deletion in TCRtg–1/1, TCRtg–1/lpr, and TCRtg–lpr/lpr Mice
Groups of mice were injected intravenously with 750 mg HA or OVA. Animals were sacrificed 1, 3, 5, and 7 days after injection. Thymi and
spleens were prepared and stained with MAbs specific for CD4 and CD8. The cell numbers from thymus and spleen in each subpopulation
were determined as in procedures described in Figure 2A. The deletion kinetics of total thymocytes (A), DP thymocytes (B), CD4 SP thymocytes
(C), total splenocytes (D), CD4 SP splenocytes (E), and CD8 SP splenocytes (F) are displayed. Values represent mean 6 SEM for 3–6 mice.
These mice are F2 progeny from an (MRL–lpr/lpr 3 HNT–TCRtg) F1 intercross.
assay was performed to confirm that the persistence of both TNF- and Fas-mediated apoptosis can contribute
to antigen-driven peripheral T cell deletion and, in thean elevated number of CD41 T cells in lpr/lpr mice in-
jected with HA and TN3 is due to the blockage of AICD absence of Fas, the TNF pathway can take its place,
and vice versa. In the absence of both the TNF andin these cells (data not shown). Analysis of cellular DNA
content by propidium iodide staining in flow cytometry the Fas receptor signaling pathways, peripheral T cell
deletion is inhibited.showed that the persistent CD41 T cells in lpr/lpr mice
injected with HA and TN3 were not in active cell cycle
(data not shown), suggesting that these cells were ini- Discussion
tially activated and underwent proliferation, but subse-
quently are not susceptible to AICD, and are quiescent The purpose of this study is to evaluate the effect of
the lpr/lpr mutant Fas gene on thymic negative selectionand long-lived. In summary, these data indicate that
Immunity
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Figure 4. HA-Induced Peripheral T Cell Hyporesponsiveness in
TCRtg–1/1, TCRtg–1/lpr, and TCRtg–lpr/lpr Mice
(A) HA-induced T cell hyporesponsiveness in both wild-type or lpr/
lpr TCRtg mice. Spleen cells (8 3 105) from TCRtg–1/1, TCRtg–1/
lpr, and TCRtg–lpr/lpr mice injected 1 day earlier with 750 mg HA
or OVA wereprepared andstimulated in vitro with a range of concen-
trations of HA 126–138 (1:5 serial dilutions from 10–0.0032 mg/ml).
The proliferative responses were measured by [3H]thymidine incor-
poration. Values represent mean 6 SEM for 4–6 mice. These mice
are F2 progeny from an (MRL–lpr/lpr 3 HNT–TCRtg) F1 intercross.
(B) CD41 T cell counts and the percentage of apoptotic cells at
different timepoints during the in vitro HA restimulation. Spleen cells
(8 3 105) from TCRtg–1/1 and TCRtg–lpr/lpr mice injected 1 day
earlier with 750 mg HA were cultured with HA peptide at a concentra-
tion of 2 mg/ml. The viable CD41 T cells and the percentage of
apoptotic cells at different timepoints were determined as described
in Experimental Procedures.
(C) Restoration of T cell hyporesponsiveness by addition of exoge-
nous IL-2. Proliferation of spleen cells (8 3 105) from HA- or OVA-
injected mice with different Fas genotypes in response to 2 mg/ml
HA peptide was assessed in the presence or absence of 10 U/ml
of recombinant mouse IL-2. Similar results were obtained in four
other experiments.
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Figure 5. Effect of TNF on HA-Induced Thymic and Peripheral T Cell
Deletion in TCRtg–1/1 and TCRtg–lpr/lpr Mice
Groups of mice were injected intraperitoneally with TN3 (200 mg 3
2), L2 (200 mg 3 2), and intraveously with 750 mg HA as described
in Experimental Procedures. Animals were sacrificed 1, 3, 5, and 7
days after injections. Thymi and spleens were prepared and stained
with MAbs specific for CD4 and CD8. The cell numbers from thymus
and spleen in each subpopulation were determined as in procedures
described in Figure 2A. The deletion kinetics of total thymocytes (A
and B) and CD4 SP splenocytes (C and D) are displayed. Values
represent mean 6 SEM for three mice. These mice are F2 progeny
from an (MRL–lpr/lpr 3 HNT–TCRtg) F1 intercross. (E) Effect of
TN3 on anergy induction. Spleen cells (8 3 105) from TCRtg–1/1,
TCRtg–1/lpr, and TCRtg–lpr/lpr mice injected with TN3 (200 mg 3
2) and HA were prepared 1 day after HA injection and stimulated in
vitro with a range of concentrations of HA 126–138 (1:5 serial dilu-
tions from 10–0.0032 mg/ml). The proliferative responses were mea-
sured by [3H]thymidine incorporation. Values represent mean 6 SEM
for 3–6 mice.
and on peripheral elimination of T cells after antigenic allowed us to compare side-by-side the effects of high
dose intravenous injection of HA peptide on inductionstimulation. The development of T cells in TCRtg–lpr/
lpr mice was indistinguishable from that in TCRtg–1/1 of thymic and peripheral T cell apoptosis in TCRtg mice
bearing or lacking Fas.mice, since both had similar T cellnumbers in the thymus
and spleen as well as same distribution of T cell subpop-
ulations. Splenocytes from TCRtg–lpr/lpr mice cultured The Fas Signaling Pathway Is Not Required
in Thymic Negative Selectionwith HA peptide in vitro showed similar proliferative re-
sponses to those from TCRtg–1/1 mice. Furthermore, Our results show that both thymocytes and peripheral
CD41 T cells in TCRtg–lpr/lpr mice followed the sameT cells from TCRtg–lpr/lpr mice in vivo stimulated with
peptide expressed the same levels of activation markers deletion kinetics after HA injection as shown in
TCRtg–1/1 mice, indicating that the mutant Fas geneCD25, CD44, and CD69 as those in TCRtg–1/1 mice.
This phenotypic and functional similarity and availability does not affect the induction of thymocyte and CD41 T
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cell apoptosis in the HNT–TCRtg model. Since neonatal Both Fas- and TNF-Mediated Apoptosis Can
Contribute to the Deletion of Peripheralthymectomy prevents lymphoid organ hyperplasia in lpr
T Cells after Antigenic Stimulationmice (Hang et al., 1984), these mice have been thought
Our results clearly show that activation-induced matureto have defects in the intrathymic development of T
T cell apoptosis still occurred in HNT–TCRtg mice in thecells. Consistent with this hypothesis, most mouse thy-
absence of Fas. To investigate other possible path-mocytes express Fas (Drappa et al., 1993; Ogasawara
way(s) further, we examined the effect of TNF, whichet al., 1993), and CD41CD81 DP thymocytes are suscep-
has potent immune regulatory functions, on HA-inducedtible to the cytolytic activity of anti-Fas antibody or FasL
CD41 T cell deletion. TNF has been well studied for its(Ogasawara et al., 1995). However, it seems unlikely that
cytolytic effects on tumor cells or transformed cell linesFas plays an important role in the negative selection
(Old, 1985; Beutler and Cerami, 1989). Current reportsof thymocytes because T cell deletion (clonal deletion)
have revealed some other examples of nontumor cellsmediated by endogenous superantigens or conven-
that also die in response to TNF, including neuronstional antigens (e.g., male H-Y antigen and pigeon cyto-
(Gelbard et al.,1993), oligodendrocytes (Wilt et al., 1995),chrome c [PCC]) is essentially normal in lpr and gld
and resting thymocytes (Hernandez-Caselles and Stut-mice and there are no obvious abnormalities in Vb gene
man, 1993). However, the role of TNF in thedown-regula-utilization among lpr and gld DN, CD41, or CD81 T cells
tion of the immune response, e.g., deletion of activated(Kotzin et al., 1988; Singer et al., 1989; Giese and David-
T cells, is still unclear.son, 1992; Sidman et al., 1992; Herron et al., 1993; Singer
TCRtg–lpr/lpr mice injected with TN3 showed a strik-
and Abbas, 1994). Our results provide further evidence
ing resistance to HA-induced T cell deletion, indicating
that Fas-mediated apoptosis is not essential in thymic
that in the absence of Fas, a TNF-mediated killing path-
negative selection. An alternative hypothesis can be
way is involved in the removal of excessive T cells after
proposed to explain high expression of Fas in thymo-
activation. This result contradicts the generally ac-
cytes and selective Fas-mediated apoptosis of DP thy- cepted idea that TNF-mediated apoptosis is seen in
mocytes: Fas expression in the thymus is necessary for tumor cells, but not in normal cells. In addition to evi-
the death (normal loss) of the unselected (neglected) dence that TNF mediates the death of normal cells (such
thymocytes, i.e., the thymocytes that fail to be positively as resting thymocytes), other evidence now indicates
selected. However, in lpr and gld mice the neglected that TNF can induce programmed cell death of normal
thymocytes, after escaping programmed cell death in mouse and human T lymphoblasts (Sarin et al., 1995)
the thymus, may migrate to the peripheral lymphoid and mediate Fas-independent mature T cell apoptosis
organs, and eventually cause the characteristic lymph- in vitro (Zheng et al., 1995). Furthermore, TNF has been
adenopathy of these mice. This hypothesis is currently shown to induce significant immunotoxicity against T
being investigated in our laboratory. cells in LCMV-infected IL-12-treated mice, and the dele-
tion of T cells can be reversed by the administration of
anti-TNF to these mice (Orange et al., 1995). These re-
Fas-Mediated T Cell Apoptosis Is Not the sults suggest a previously unappreciated toxic effect of
Only Pathway for Clonal Elimination TNF, i.e., killing of specific T cell populations undergoing
activation and proliferation in response to stimulationof Peripheral CD41 T Cells After
during viral infection. Our results provide in vivo evi-Antigenic Stimulation
dence that TNF-mediated apoptosis is responsible forPeripheral CD41 T cells from TCRtg–lpr/lpr mice chal-
the deletion of peripheral T cells after antigenic stimula-lenged with HA peptide in vivo followed the same activa-
tion. This additional role of TNF could be important intion and deletion kinetics as shown in TCRtg–1/1 mice.
the regulation of T cell responses and the maintenanceThis result demonstrates that the defective Fas gene in
of homeostasis in the immune system.HNT–TCRtg animals does not prevent activation-in-
TNF-mediated deletion is not the only pathway for theduced deletion of mature peripheral CD41 T cells,
death of activated T cells. Only blockage of both thestrongly implying that a different Fas-independent path-
TNF and Fas killing pathways could significantly inhibitway(s) may be responsible for the death of activated T
activation-induced T cell apoptosis in HNT–TCRtg lines.cells. These data conflict with recent results that indi-
These results also confirm the existence of a Fas-depen-
cated that Fas plays an obligatory role in activation-
dent pathway responsible for the deletion of mature T
induced apoptosis of mature peripheral T cells (Singer
cells afterantigenic stimulation (Singer and Abbas, 1994;
and Abbas, 1994). Based on our results, we postulate
Van Parijs et al., 1996).
that Fas-mediated T cell apoptosis could play a major It has been generally accepted that the autoimmune
role in peripheral elimination of either activated T cells phenotype in lpr or gld mice is due to the major genetic
undergoing excessive clonal expansion after antigen defect in Fas or in FasL, respectively. Presumably, these
stimulation, or autoreactive T cells escaping from thymic mice fail to perform Fas-mediated T cell apoptosis and
negative selection and then encountering self-antigens accumulate abnormal DN T cells in the peripheral
in the peripheral tissues. However, Fas-mediated lymphoid organs. In view of the data presented here, it
apoptosis is certainly not the only pathway for the dele- will be important to evaluate the existence of other Fas-
tion of mature T cells after antigenic stimulation. The independent killing pathway(s), such as TNF, in the regu-
existence of multiple (parallel or redundant) pathways lation of T cell responses and their role in the develop-
of T cell deletion may be required to down-regulate ment of autoimmune diseases.
excessive immune responses and maintain the homeo- Splenic and thymic cells from lpr mice appear to ex-
press higher levels of TNFa than 1/1 mice (Tsai et al.,stasis of immune system.
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1995), and stimulated T cells from lpr or gld mice can In particular, these results differ from the in vivo findings
of Abbas and his colleagues indicating that Fas is criticalrapidly induce and secrete TNFa (Davidson et al., 1991;
Zheng et al., 1995), suggesting that the expression of in activation-induced deletion of mature peripheral T
cells in TCRtg mice. TNF clearly plays an important roleFasL and TNF could be differentially regulated. How-
ever, TNF-mediated apoptosis does not seem to play a in the deletion of peripheral T cells in HNT–TCRtg–lpr/
lpr mice after antigenic stimulation. This pathway ap-critical role in the deletion of DN T cells in lpr or gld
mice, even though they have higher expression of TNF. pears to be inactive in 2B4/lpr mice (the Abbas TCRtg–
lpr/lpr mice) when challenged with PCC. The discrep-Perhaps only under an acute stress, such as high dose
antigen stimulation, do T cells become sufficiently acti- ancy in results between these two models is unlikely to
be due to the effect of peptide dosage (e.g., a singlevated to be susceptible to TNF-triggered apoptosis. As
recently shown by Henkart and his colleagues (Sarin et 750 mg HA injection in HNT–TCRtg mice versus 100
mg PCC peptide given in three injections in 2B4–TCRtgal., 1995), TNF can induce apoptotic death of normal
mouse and human T lymphocyte blasts in vitro. This mice), because bothHNT–TCRtg–1/1 and HNT–TCRtg–
lpr/lpr mice injected with single lower doses of peptidescytotoxic effect is independent of the Fas-mediated
death pathway (Sarin et al., 1995). It is possible that the (450, 300, or 150 mg) showed similar deletion kinetics
(data not shown). We can also rule out the possibilityFas-mediated killing pathway is more predominant or
primary than the TNF pathway. that the genetic background differences between MRL
and B6 mice may affect the induction of TNF pathway,TNF and FasL mediate their biological effects through
interaction with structurally related receptors belonging because HNT–TCRtg–lpr/lpr mice on either the MRL or
B6 background showed identical activation-induced Tto the TNFR superfamily (reviewed by Smith et al., 1994).
Two distinct membrane receptors for TNF of apparent cell deletion. Furthermore, we have determined and
compared the expression of the transmembrane formmolecular mass 55–60 kDa (TNFR60) and 70–80 kDa
(TNFR80) have significant homologies in their extracellu- of TNF (mTNF) on activated CD41 T cells from several
TCRtg systems, and found that the expression of mTNFlar domains with repeat cysteine-rich sequences. Most
cell lines and primary tissues coexpress both receptors, is significantly higher in activated CD41 T cells of HNT–
TCRtg mice than in other mice, e.g., myelin basic proteinalthough expression of TNFR60 and TNFR80 is controlled
by distinct mechanisms (reviewed by Grell et al., 1995). peptide-specific TCRtg (H.-K. S., C. Pearson, and
H. O. M., unpublished data). For these reasons, weDifferent TNFR60- and TNFR80-associated proteins have
currently been cloned and characterized (Rothe et al., would postulate that different TCRtg systems (i.e., differ-
ent TCR affinity, different TCRtg expression, different1994; Hsu et al., 1995). The results suggest that these
two receptors could have independent roles in separate usage of TCR Va and Vb repertoires, or different MHC
restriction) may utilize distinct pathways to mediate pro-cellular responses. The recent creation of TNFR60 and
TNFR80 knockout mice should be very helpful in dis- grammed cell death, a difference that may be of great
physiological importance.secting these complex signaling pathways, especially
in determining which receptor (or both) is responsible However, despite these contradictions, our results are
in agreement with the in vivo finding that SEB- or anti-for the death of activated T cells in TCRtg–lpr/lpr mice.
The targets of the Fas and TNFR signaling pathways CD3-induced peripheral T cell apoptosis can occur with-
out Fas (Giese and Davidson, 1995; Tucek-Szabo et al.,are also likely to involve the regulation of the Bcl-2 family
of proteins, which function to suppress or activate this 1996) and the in vitro findings that TNF triggers the
apoptosis of lymphoblasts (Sarin et al., 1995) and thatcell death program (Oltvai and Korsmeyer, 1994). In con-
trast with Bcl-xL, which appears to provide a survival both TNF- and Fas-induced apoptosis are involved in
the death of anti-CD3-stimulated T cells (Zheng et al.,signal for the maintenance of more immature DP thymo-
cytes before positive selection, Bcl-2 has been impli- 1995).
cated in the maintenance of mature T cells (Grillot et
al.,1995). To evaluate thepossibility that overexpression
The Roles of the Fas Receptor and TNF in Highof bcl-2 in HNT–TCRtg mice could confer resistance to
Dose Antigen-Induced THA-induced T cell apoptosis, bcl-2–36 mice overex-
Cell Hyporesponsivenesspressing an Em–bcl-2 transgene (Strasser et al., 1991)
The results discussed above clearly indicate that thewere crossed toHNT–TCRtg mice. Similar T cell deletion
lpr/lpr mutant Fas gene cannot, in all cases, preventkinetics were observed in both HNT–TCRtg and TCRtg–
antigen-induced T cell apoptosis. In addition, the roleBcl-2 double transgenic mice injected with HA peptide,
of Fas in the induction of T cell anergy or hyporespon-indicating that bcl-2 overexpression does not block the
siveness is unclear. Following antigen stimulation, TAICD of T cells after antigenic stimulation (H.-K. S.,
cells are activated to proliferate and secrete cytokines,R. S. L., and H. O. M., unpublished data).
or to become anergic depending on the expression of
costimulatory molecules on antigen-presenting cells,
the nature of the antigen-presenting cells involved, andInduction of TNF-Mediated Apoptosis
Is TCRtg Dependent on the dose and nature of the antigen, and the presence
of adjuvants (Lenardo, 1991; Russell et al., 1991; Ham-Our results contradict the generalization that Fas plays
an essential role in the induction of peripheral deletion merling et al., 1993; Moskophidis et al., 1993; Russell
et al., 1993; Critchfield et al., 1994). If activated T cellsof activated T cells (Owen-Schaub et al., 1992; Drappa
et al., 1993; Klas et al., 1993; Russell et al., 1993; Scott are triggered again through the TCR, a genetic program
leading to cell death is activated (Zheng et al., 1995).et al., 1993; Singer and Abbas, 1994; Mogil et al., 1995).
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Determination of Serum Anti-DNA Antibody and RFOur studies of in vitro T cell responses to HA peptide
The concentrations of serum anti-DNA (immunoglobulin G2ashow that the defective Fas gene did not affect the
[IgG2a]) and RF (IgG2a) were determined as described elsewhereinduction of T cell hyporesponsiveness. This rapid anti-
(Mountz et al., 1990). In brief, sera were collected by retro-orbital
genic peptide-induced anergy or hyporesponsiveness sinus puncture from both TCRtg–lpr/lpr and nontransgenic lpr/lpr
in mature T cells was also demonstrated at the single littermates at ages 6, 16, and 24 weeks. For detection of anti-dsDNA
antibody, the 96-well microtiter plates were precoated with poly-L-cell level via calcium flux experiments (data not shown).
lysine (Sigma Chemical Company) and subsequently with dsDNAOne interesting point is that the antigen-specific cells
(Sigma Chemical Company). Control poly-L-lysine–precoated wellsbecome anergic at the peak of cellular proliferation prior
were coated with poly-L-glutamic acid. Sera were initially dilutedto deletion (Moskophidis et al., 1993; Liblau et al., 1996).
200-fold with borate-buffered saline (BBS; 25 mM borate, 140 mM
This chronology favors the idea that anergy and deletion NaCl [pH 7.4]) containing 1% bovine serum albumin and assayed
are distinct stages in a continuing process, i.e., before after 4 hr incubation at 228C. After each incubation, the plates were
washed extensively with BBS. Bound anti-dsDNA antibody was de-T cells start to undergo apoptosis, they first become
tected with alkaline phosphatase–conjugated isotype-specific goatanergic. To investigate this possibility further, T cell pro-
anti-mouse IgG2a (Caltag) using p-nitrophenylphosphate (Sigmaliferative responses to in vitro HA peptide in TCRtg–lpr/
Chemical Company) as a substrate. RF was determined as de-lprmice injected with TN3 and HA wereexamined. These
scribed above except that the 96-well microtiter plates were coated
T cells were hyporesponsive to in vitro peptide stimula- with affinity-purified rabbit IgG (4 mg/ml; Sigma Chemical Company).
tion, even though they were not going to undergo activa- Immunoglobulin isotype standards were assayed in each experi-
ment and the absorbance at 405 nm for sera and standards weretion-induced apoptosis. This result does not support
determined on a Titertek Multiskan microplate reader (Flow Labora-the idea that anergy induction is the preliminary stage
tories).in commitment to T cell apoptosis. To the contrary, this
result indicates that the process of anergy induction and
Peptide Preparation and Administration,apoptosis induction can be dissociated.
and TN3 TreatmentThe cellular and molecular mechanisms for the dele-
The peptide HA 126–138 (HNTNGVTAACSHE) and the control I-Ad
tion of immature T cells in the thymus are different from binding peptide OVA 323–339 (ISQAVHAAHAEINEAGR) were syn-
those of peripheral T cells. T cell tolerance to self-anti- thesized by standard Fmoc chemistry using an Applied Biosystems
gens is acquired through both thymic and extrathymic 431A synthesizer. The peptides were purified on high pressure liquid
chromatography (RAININ) before use and their composition was(peripheral) events. Deletion of self-reactive T cells in
confirmed by amino acid analysis and mass spectrometry (whichboth sites plays an important role in the maintenance
was provided by the University of California San Francisco Massof immune tolerance (Kappler et al., 1987; Kisielow et
Spectrometry Facility). The peptides (750 mg) were solubilized in
al., 1988; Fields and Loh, 1992; Hammerling et al., 1993). phosphate-buffered saline and administered by intravenous injec-
Understanding the multiple mechanisms for the deletion tion in a volume of 250 ml. Mice were sacrificed 1, 3, 5, and 7
of thymocytes in the thymus and mature T cells in the days after peptide injection and thymus, spleen, and lymph nodes
(popliteal, inguinal, and axillary) were harvested for staining andperiphery may help to gain further insight into the break-
flow cytometric analysis. The murine TNF-blocking MAb (TN3.19.12,down of immune tolerance and the pathogenesis of au-
hamster IgG1) and the immunoglobulin isotype-matched controltoimmune diseases.
MAb (L2.3D9, hamster IgG1) were prepared as described (Sheehan
et al., 1989) and provided by Dr. R. Schreiber. Some mice were first
injected intraperitoneally with 200 mg of TN3 or L2 in a volume of
Experimental Procedures 100 ml 18 hr before peptide injection and then injected with second
dose of these MAbs 1 hr before peptide injection.
Generation and Screening of TCRtg–lpr/lpr Mice
The HNT–TCRtg mice were generated as described elsewhere (Scott
Flow Cytometryet al., 1994). For our study, one line, in which approximately 50
Single cell suspensions prepared from thymus, spleen, and lymphcopies of the TCR a transgene and 40 copies of the TCR b transgene
nodes were stained at 48C in phosphate-buffered saline containinghad integrated in the same chromosomal location, was backcrossed
1% fetal calf serum and 0.02% NaN3. Biotin-, fluorescein-, and phy-at least 6 times on the B10.D2 (H-2d) background. MRL/MpJ–lpr/lpr
coerythrin-conjugated MAbs specific for mouse TCR Vb8 (F23.1),(MRL–lpr/lpr, H-2k) and C57BL/6–lpr/lpr (B6–lpr/lpr, H-2b) mice were
CD4, CD8a, CD69, CD44 (Pgp-1), CD25 (IL-2R), Fas/APO-1 (CD95)obtained from Jackson Laboratories (Bar Harbor, Maine). Mice were
(Pharmingen), and CD3e (Caltag) were used for double or triplebred at Stanford University in the Research Animal Facility and kept
staining. Viable cells (30–50 3 103 cells per sample), gated by exclu-under barrier conditions. HNT–TCRtg mice were bred to MRL–lpr/
sion of propidium iodide–positive cells, were analyzed on a Flasherlpr and B6–lpr/lpr mice. F1 progeny with the TCR transgene were
flow cytometer (Stanford Shared FACS Facility).intercrossed to TCR transgene negative mice. Subsequent genera-
tions were screened for the TCR transgene and I-Ad by flow cytome-
try of peripheral blood cells using MAbs against Vb8 (F23.1) and T Cell Proliferation Assay and Viable Cell Counts
I-Ad (AMS-32.1), respectively, and lpr/lpr genotype was determined Spleens were prepared from TCRtg–1/1 and TCRtg–lpr/lpr mice
by PCR analysis of tail DNA. Based on the genomic structure and injected with or without HA peptide. Spleen cell suspensions were
DNA sequence of the Fas antigen gene in lpr mice (Adachi et al., treated with Tris-buffered ammonium chloride to eliminate the red
1993), three specific PCR primers were designed to discriminate blood cells, washed, and resuspended at a cell concentration of
the1/1, 1/lpr, or lpr/lpr Fasgenotype: primer 1 (sense), 59-GGTCAC 4 3 106/ml in RPMI 1640 supplemented with 5% fetal calf serum,
CCATATTTTCACTTT-39; primer 2 (antisense), 59-GGCTGCTGCTTA HEPES buffer, L-glutamine, penicillin, and streptomycin. Cells were
GCATCTCTG-39; and primer 3 (antisense), 59-GCCACACCCGTGCA cultured in triplicate in 96-well flat-bottomed microtiter plates (200
CCTTTCT-39. Tail DNA was prepared by proteinase K (Boehringer ml/well) in the presence of HA peptide 126–138 or anti-CD3 MAb.
Mannheim) digestion, phenol/chloroform (Applied Biosystems) ex- After 48 hr, cultures were pulsed with 1 mCi of [3H]thymidine and
traction,and ethanol precipitation. A 254 bp PCR product was ampli- harvested 16 hr later. SEM were less than 15% of the mean. Cultured
fied from lpr/lpr mice, a 327 bp product for 1/1 mice, and both cells at different timepoints were counted and stained with fluores-
products from heterozygotes. These PCR products were illustrated cein-conjugated anti-CD4 and propidium iodide. The absolute num-
by electrophoresis on a 1.5% agarose gel. All mice used for peptide ber of CD41 T cells, and the percentage of viable cells were deter-
mined by flow cytometer as described above.injection were 6–8 weeks of age.
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